Neutropenia Treatment Market to Garner $19.30 Bn, Globally, by 2027 at 5.4% CAGR, Says Allied Market Research
Rise in prevalence of leukemia, surge in R&D efforts and development of new drugs, and fundamental shift from branded drugs to biosimilars in cancer supportive treatment drive the global neutropenia treatment marketPORTLAND, Oregon, June 8, 2020 /PRNewswire/ -- Allied Market Research recently published a report, "Neutropenia Treatment Market by Treatment…
bubmagJune 8, 2020